Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial - Folegatti, P M; Ewer, K J; Aley, P K (Lancet (London, England), 2020)
. doi:10.1016/S0140-6736(20)31604-4